Fresh Rounds

Outlook Therapeutics, Inc. funding

Outlook Therapeutics, Inc., a biotechnology company based in Iselin, NJ, filed a Form D with the SEC on May 7, 2026 and reported a $5M offering.

Amount raised$0
Offering size$5M
Filed with the SECMay 7, 2026
First saleApril 23, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationIselin, NJ
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far2
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in New Jersey